Gene–pathway–organ perspective on quercetin in diabetic complications: A narrative review of preclinical evidence
Pakistan Journal of Pharmaceutical Sciences · 01.02.2027
DOI: 10.36721/pjps/2026.40.16396.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 01.11.2026. Verfasst von Jie Zhan. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
Diabetic complications involve multiple mechanisms, including metabolic disorders, oxidative stress, inflammation, fibrosis and apoptosis. Quercetin possesses multi-target regulatory potential, but relevant preclinical evidence remains scattered across different organs and signaling pathways. This narrative review aims to synthesize rodent evidence on quercetin-related genes, signaling pathways and organ protection in diabetic complications from a gene–pathway–organ perspective. Relevant rodent studies published from inception to June 2025 were searched in PubMed, EMBASE, Web of Science, Cochrane Library and Springer Link databases. Seventy-eight studies were included after screening. Due to significant heterogeneity among studies, a narrative approach was used for evidence synthesis. Quercetin mainly regulates pathways such as AMPK, PI3K/Akt, Nrf2/HO-1, NF-κB, TGF-β/Smad3, SIRT1 and NLRP3 and is involved in metabolic, cardiovascular, hepatic, renal, nervous, intestinal, wound-healing, reproductive and retinal systems. Evidence is strong in the metabolic-cardiovascular, hepatic and renal systems, moderate in the nervous and intestinal systems and limited in other systems. Current animal evidence suggests that quercetin may act as a multi-target regulator in the intervention of diabetic complications. This "gene-pathway-organ" framework can serve as a hypothesis-generating tool to identify key molecular hubs, compare the strength of evidence across different organs and guide subsequent mechanism validation and translational research.
Zitieren
APA
Zhan, J. (2027). Gene–pathway–organ perspective on quercetin in diabetic complications: A narrative review of preclinical evidence. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16396.1
Vancouver
Zhan J. Gene–pathway–organ perspective on quercetin in diabetic complications: A narrative review of preclinical evidence. Pakistan Journal of Pharmaceutical Sciences. 2027. doi:10.36721/pjps/2026.40.16396.1
BibTeX
@article{Zhan2027,
author = {Zhan, Jie},
title = {Gene–pathway–organ perspective on quercetin in diabetic complications: A narrative review of preclinical evidence},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2027},
doi = {10.36721/pjps/2026.40.16396.1}
}
EUVIMED